Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P08908 (
5-HT1A
)
5,574
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mammalian
HES1
and HES5 are abundant in developing CNS and inhibit neurogenesis, while HES6 promotes neurogenesis. An early serotonergic differentiation marker, the
5-HT1A
receptor, is repressed by HES5 and DEAF1 which recognize the C(-1019), but not G(-1019) allele of a human
5-HT1A
promoter polymorphism associated with mood disorders. We tested whether
HES1
and HES6 regulate transcriptional activity at this element.
HES1
strongly repressed
5-HT1A
transcription in neuronal and non-neuronal cells, while HES6 reversed
HES1
- and HES5-mediated repression. Mutation of a putative HES consensus site blocked
HES1
and HES5, but, unlike HES5,
HES1
repressed at the G(-1019) allele. To address its role in vivo, the temporal expression of
5-HT1A
receptor RNA and protein was examined in
HES1
-/- mice, and elevated levels in E12.5 hindbrain and midbrain were observed. Thus,
HES1
and HES6 oppositely regulate
5-HT1A
receptor transcription and
HES1
is required for its correct developmental expression.
...
PMID:HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression. 1849 74